Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Maxvax Biotechnology Limited Liability Company

Clinical trials sponsored by Maxvax Biotechnology Limited Liability Company, explained in plain language.

Not yet recruiting 1 Not yet finished but already full! 1

New RSV vaccine trial aims to protect women from respiratory virus

⭐️ VACCINE ⭐️ Not yet recruiting

This early-stage study tests a new vaccine (MKK900) against respiratory syncytial virus (RSV) in 120 healthy women aged 18-49. The goal is to check if the vaccine is safe and triggers a strong immune response. Participants will be monitored for side effects and their antibody lev…

Phase: PHASE1 • Sponsor: MAXVAX Biotechnology Limited Liability Company • Aim: ⭐️ VACCINE ⭐️

Last updated May 11, 2026 20:47 UTC